fintopic.
Docs Get the API

Shionogi acquires IntraBio for $2 billion

7 statements from 7 sources, Oct 5, 2026 07:07 UTC to Oct 10, 2026 05:13 UTC
Part of Deals & M&A
News
Updated
Front page

Statements (7)

  1. Neutral

    Shionogi is acquiring IntraBio for an undisclosed amount.

    finance.yahoo.com
  2. Bullish

    Shionogi will acquire US-based IntraBio for $2 billion to expand its rare disease drug business

    asia.nikkei.comHigh importance
  3. Bullish

    Shionogi pays $2B to acquire IntraBio

    biopharmadive.comHigh importance
  4. Bullish

    Shionogi is paying $2 billion for IntraBio

    endpoints.newsHigh importance
  5. Bullish

    Shionogi is acquiring IntraBio for US$ 2 billion to strengthen its rare disease area

    valor.globo.comHigh importance
  6. Bullish

    Shionogi approved an agreement to acquire IntraBio Inc.

    businesswire.comHigh importance
  7. Bullish

    Shionogi will acquire IntraBio for $2 billion

    wsj.comHigh importance